Human Tumor Sequencing Project (HuTS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Eric Topol, MD, Scripps Translational Science Institute
ClinicalTrials.gov Identifier:
NCT01608230
First received: May 25, 2012
Last updated: May 12, 2014
Last verified: May 2014

May 25, 2012
May 12, 2014
April 2010
April 2014   (final data collection date for primary outcome measure)
Determine biomarkers of clinical utility and copy number variants through genetic analysis. [ Time Frame: four years ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01608230 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Human Tumor Sequencing Project
Human Tumor Sequencing Project

This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Cancer

Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
35
April 2014
April 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of a solid tumor or blood borne cancer
  • 18 years or older
  • Eligible to have blood drawn
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01608230
09-5270
No
Eric Topol, MD, Scripps Translational Science Institute
Scripps Translational Science Institute
Not Provided
Not Provided
Scripps Translational Science Institute
May 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP